C. López

Identification of a Novel Risk Locus for Multiple Sclerosis at 13q31.3 by a Pooled Genome-Wide Scan of 500,000 Single Nucleotide Polymorphisms

D. Craig, X. Montalban, A. Navarro, 2008, PloS one.

Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis.

X. Montalban, S. Baranzini, J. Oksenberg, 2009, Clinical immunology.

Altered maturation of circulating dendritic cells in primary progressive MS patients

X. Montalban, M. Tintoré, M. Comabella, 2006, Journal of Neuroimmunology.

A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis.

X. Montalban, J. Río, M. Prinz, 2009, Brain : a journal of neurology.

Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis

À. Rovira, X. Montalban, N. Téllez, 2008, Journal of Neurology.

Variations in chemokine receptor and cytokine expression during pregnancy in multiple sclerosis patients

X. Montalban, M. Tintoré, J. Sastre-Garriga, 2006, Multiple sclerosis.

A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis.

J. Río, M. Comabella, L. Nonell, 2009, Brain : a journal of neurology.